Page results
-
This page has been written by the Physiotherapy Services at the Royal London Hospital for Integrated Medicine. It is for patients who have been referred to the clinic.
-
Radiotherapy Department Patient Information series no. 18 - prostate brachytherapy prostate high dose rate (HDR) brachytherapy
-
Overview of the UCLH ambulatory care service for adults with cancer. This service allows people to have their cancer treatment at outpatient appointments, without needing to stay overnight in hospital.
-
This information is for patients who are receiving radiotherapy to the prostate or prostate bed. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
-
This page provides information for patients visiting the Inflammatory Bowel Disease clinic.
-
This information outlines the things that you need to take home after your robotic prostatectomy.
-
Information about the integrated cancer care service at the Royal London Hospital for Integrated Medicine.
-
Information about the integrated women's service at the Royal London Hospital for Integrated Medicine
-
The Ataxia Centre brings together a team of specialists, with expertise in the diagnosis, management and research of all forms of ataxia.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
File results
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0249 - Treatments for clotting disorders - Haemophilia B, Von Willebrand Disease
-
FOI/2023/0242 - Treatment of Haemophilia A
-
FOI/2023/0224 - Patients prescribed medical equipment for use in the home
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment